Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencing

Zeng Zhen; Zhao Hailong; Dorr Mary Beth; Shen Judong; Wilcox Mark H.; Poxton Ian R.; Guris Dalya; Li Junhua; Shaw Peter M.

首页> 外文期刊>Anaerobe >Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencing

【24h】

Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencing

机译：Bezlotoxumab预防梭菌性艰难梭菌性复发：与全基因组测序中的重新捕获区分复发

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Bezlotoxumab has been shown to prevent Clostridium difficile infection recurrence (rCDI) in high-risk patients.

机译：背景：Bezlotoxumab已被证明在高危患者中预防梭菌艰难的感染复发（RCDI）。

著录项

来源
《Anaerobe 》 |2020年第2020期| 共6页
作者
Zeng Zhen; Zhao Hailong; Dorr Mary Beth; Shen Judong; Wilcox Mark H.; Poxton Ian R.; Guris Dalya; Li Junhua; Shaw Peter M.;
展开▼
作者单位

Merck &

Co Inc Kenilworth NJ USA;

BGI Shenzhen Shenzhen Peoples R China;

Merck &

Co Inc Kenilworth NJ USA;

Merck &

Co Inc Kenilworth NJ USA;

Leeds Teaching Hosp Leeds W Yorkshire England;

Univ Edinburgh Edinburgh Midlothian Scotland;

Merck &

Co Inc Kenilworth NJ USA;

BGI Shenzhen Shenzhen Peoples R China;

Merck &

Co Inc Kenilworth NJ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类微生物学 ;
关键词
Bezlotoxumab; Clostridium difficile infection; Recurrence; Reinfection; Relapse; Single nucleotide polymorphism; Whole genome sequencing;

机译：Bezlotoxumab;Clostridium艰难梭菌感染;复发;再感染;复发;单核苷酸多态性;全基因组测序;

相似文献

外文文献
中文文献
专利

1. Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencing [J] . Zeng Zhen, Zhao Hailong, Dorr Mary Beth, Anaerobe . 2020 ,第期

机译：Bezlotoxumab预防梭菌性艰难梭菌性复发：与全基因组测序中的重新捕获区分复发
2. Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with clostridium difficile [J] . EyreD.W., BabakhaniF., GriffithsD., The Journal of Infectious Diseases . 2014 ,第9期

机译：全基因组测序表明，在预防艰难梭菌的再感染和感染复发方面，非达索星优于万古霉素
3. Recurrence of symptoms in Clostridium difficile infection--relapse or reinfection? (see comments) [J] . Wilcox MH, Fawley WN, Settle CD, The Journal of hospital infection . 1998 ,第2期

机译：艰难梭菌感染的症状复发-复发还是再次感染？（看评论）
4. CREST - Risk Prediction for Clostridium Difficile Infection Using Multimodal Data Mining [C] . Cansu Sen, Thomas Hartvigsen, Elke Rundensteiner, European conference on machine learning and principles and practice of knowledge discovery in databases . 2017

机译：CREST-使用多模式数据挖掘的艰难梭菌感染风险预测
5. A Possible Role of Clostridium difficile Association with the GI Tract in Relapsing Clostridium difficile Infection [D] . Ashraf, Asiyya 2019

机译：难辨梭状芽胞杆菌与胃肠道的关联在复发性难辨梭状芽胞杆菌感染中的可能作用
6. Bezlotoxumab (BEZ) for Prevention of Clostridium difficile Infection (CDI) Recurrence (rCDI): Distinguishing Relapse from Reinfection with Whole Genome Sequencing (WGS) [O] . Mary Beth Dorr, Zhen Zeng, Mark Wilcox, 2017

机译：预防难治性梭状芽胞杆菌感染（CDI）复发（rCDI）的贝洛单抗（BEZ）：通过全基因组测序（WGS）区分再感染的复发
7. Bezlotoxumab (BEZ) for Prevention of Clostridium difficile Infection (CDI) Recurrence (rCDI): Distinguishing Relapse from Reinfection with Whole Genome Sequencing (WGS) [O] . Mary Beth Dorr, Zhen Zeng, Mark Wilcox, 2017

机译：用于预防梭菌差异感染（CDI）复发（RCDI）的Bezlotoxumab（Bez）：区分复发从整个基因组测序（WGs）

Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencing

摘要

著录项

相似文献

相关主题

期刊订阅